antibody 3d representation

Pharmacodynamics

<a href="https://www.bioagilytix.com/blog/category/flow-cytometry/">Flow Cytometry</a>

Receptor Occupancy Flow Cytometry Assays

  • April 14, 2023

This is the final blog in our three-part flow cytometry series. Part 1 highlighted the broad application of flow cytometry for bioanalysis, part 2 investigated…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/flow-cytometry/">Flow Cytometry</a>

Flow Cytometry – What’s Old is New Again

  • March 27, 2023

Analytical testing of therapeutic compounds often requires data at the single-cell level. Flow cytometry is a versatile technology that can analyze multiple characteristics of cells…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/flow-cytometry/">Flow Cytometry</a>

Flow Cytometry in Bioanalysis: Application, Utility, and Recent Advancements

  • September 29, 2021

Flow Cytometry in Drug Development Flow cytometry is a technique that is used to analyze multiple characteristics of single cells. These characteristics include cell size,…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/pharmacokinetics/">Pharmacokinetics</a>

The Difference Between Pharmacokinetics and Pharmacodynamics

  • October 5, 2020

In the United States, the safety and efficacy of prescription and over-the-counter drugs are a top priority for our government, medical professionals, and pharmaceutical companies.…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

The Fit for Flow Cytometry, Part 1: Ideal for Receptor Occupancy Assessment

  • April 17, 2019

Flow cytometry is an ideal platform for many applications involving the study of complex cell populations. In the first blog of our new “The Fit…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

Immuno-oncology in 2018: Overcoming Challenges to Revolutionize Cancer Treatment

  • May 2, 2018

Many immuno-oncology therapies are seeing success and showing promise for the future, including CAR-T cells, tumor-infiltrating lymphocytes (TILs), checkpoint inhibitors, and natural killer cell therapies.…

Find Out More